Skip to main content
SpringerLink
Log in

Vasodilators

  • Chapter
Handbook of Pediatric Cardiovascular Drugs

Pharmacological manipulation of afterload or systemic vascular resistance (SVR) has become increasingly important in the management of pediatric cardiac patients, just as it has for adult cardiac patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chobarian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289:2560–2572.

    Article  Google Scholar 

  2. von Vigier RO, Mozzetti S, Truttmann AC, et al. Cough is Common in Children Prescribed Converting Enzyme Inhibitors. Nephron 2000; 84:98.

    Article  Google Scholar 

References

  1. Chobarian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289:2560–2572.

    Article  Google Scholar 

  2. Leversha AM, Wilson NJ, Clarkson PM, et al. Efficacy and Dosage of Enalapril in Congenital and Acquired Heart Disease. Arch Dis Child 1994; 70:35.

    Article  PubMed  CAS  Google Scholar 

  3. Marcadis ML, Kraus DM, Hatzopoulos FK, et al. Use of Enalaprilat for Neonatal Hypertension. J Pediatr 1991; 119:505.

    PubMed  CAS  Google Scholar 

  4. von Vigier RO, Mozzetti S, Truttmann AC, et al. Cough is Common in Children Prescribed Converting Enzyme Inhibitors. Nephron 2000; 84:98.

    Article  Google Scholar 

References

  1. Chase SL, Sutton JD. Lisinopril: A New Angiotensin-Converting Enzyme Inhibitor. Pharmacotherapy 1989; 9:120.

    PubMed  CAS  Google Scholar 

References

  1. Epstein BJ, Gums JG. Angiotensin Receptor Blockers Versus ACE Inhibitors: Prevention of Death And Myocardial Infarction in High-Risk Populations. Ann Pharmacother 2005; 39:470–480.

    Article  PubMed  CAS  Google Scholar 

  2. Ellis D, Moritz ML, Vats A, Janosky JE. Antihypertensive and Renoprotective Efficacy and Safety of Losartan. A Long-Term Study in Children with Renal Disorders. Am J Hypertens 2004; 7:928–935.

    Google Scholar 

  3. Cozaar® (Losartan potassium). In Physicians’ Desk Reference. 60th Edition. Thomson PDR, Montvale, New Jersey. 2006. pp. 1213–1918.

    Google Scholar 

References

  1. Flynn JT, Pasko DA. Calcium Channel Blockers: Pharmacology and Place in Therapy of Pediatric Hypertension. Pediatr Nephrol 2000; 15:302.

    Article  PubMed  CAS  Google Scholar 

References

  1. Flynn JT, Smoyer WE, Bunchman TE. Treatment of Hypertensive Children with Amlodipine. Am J Hypertens 2000; 13:1061–1066.

    Article  PubMed  CAS  Google Scholar 

  2. Tallian KB, Nahata MC, Turman MA, et. al. Efficacy of Amlodipine in Pediatric Patients with Hypertension. Pediatr Nephrol 1999; 13:304–310.

    Article  PubMed  CAS  Google Scholar 

References

  1. Tobias JD. Nicardipine to Control Mean Arterial Pressure After Cardiothoracic Surgery in Infants and Children. Am J Ther 2001; 8:3–6.

    Article  PubMed  CAS  Google Scholar 

  2. Milou C, Debuche-Benouachkou V, Semama DS, et al. Intravenous Nicardipine as a First-Line Antihypertensive Drug in Neonates. Intensive Care Med 2000; 26:956–958.

    Article  PubMed  CAS  Google Scholar 

  3. Gouyon JB, Geneste B, Semama DS, et al. Intravenous Nicardipine in Hypertensive Preterm Infants. Arch Dis Child Fetal Neonatal Ed 1997; 76:F126–127.

    Article  PubMed  CAS  Google Scholar 

References

  1. Corwin S, Reiffel JA. Nitrate Therapy for Angina Pectoris. Arch Int Med 1985; 145:538.

    Article  CAS  Google Scholar 

  2. Elkayam V. Tolerance to Organic Nitrates: Mechanisms, Clinical Relevance, and Strategies for Prevention. Ann Int Med 1991; 114:667–677.

    PubMed  CAS  Google Scholar 

  3. Taketomo CK, Hodding JH, Kraus DM. Lexi-Comp’s Pediatric Dosage Handbook, 13th Edition, 2006.

    Google Scholar 

References

  1. Palmer RF, Lasseter KC. Drug Therapy: Sodium Nitroprusside. N Engl J Med 1975; 292:294–297.

    PubMed  CAS  Google Scholar 

  2. Vessey CJ, Cole PV. Blood Cyanide and Thiocyanate Concentrations Produced by Long-Term Therapy with Sodium Nitroprusside. Br J Anaesth 1985; 57:148–155.

    Article  Google Scholar 

References

  1. Tobias JD. Preoperative blood pressure management of children with cathecholamine-secreting tumors: time for a change. Pediatr Anesth 2005; 15:537–540.

    Article  Google Scholar 

  2. Kawamura M, Minamikawa O, Yokochi H, Maki S, Yasuda T, Mizukawa Y. Combined use of phenoxybenzamine and dopamine for low cardiac output syndrome in children at withdrawal from cardiopulmonary bypass. Br Heart J 1980; 43:388–392.

    Article  PubMed  CAS  Google Scholar 

  3. Kulik A, Rubens FD, Gunning D, Bourke ME, Mesana TG, Ruel M. Radial artery graft treatment with phenoxybenzamine is clinically safe and may reduce perioperative myocardial injury. Ann Thorac Surg 2007; 83:502–509.

    Article  PubMed  Google Scholar 

  4. Kiran U, Zuber K, Kakani M. Combination of low-dose phenoxybenzamine and sodium nitroprusside in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2006; 20:291–292.

    Article  PubMed  Google Scholar 

  5. Kiran U, Makhija N, Das SN, Bhan A, Airan B. Combination of phenoxybenzamine and nitroglycerin: effective control of pulmonary artery pressures in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2005; 19:274–275.

    Article  PubMed  Google Scholar 

  6. Motta P, Mossad E, Toscaca D, Zestos M, Mee R. Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery. J Cardiothorac Vasc Anesth 2006; 20:291–292.

    Article  Google Scholar 

  7. Motta P, Mossad E, Toscana D, Zestos M, Mee R. Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery. J Cardiothorac Vasc Anesth 2005; 19: 54–59.

    Article  PubMed  CAS  Google Scholar 

  8. Li DM, Mullaly R, Ewer P, Bell B, Eyres RL, Brawn WJ, Mee RB. Effects of vasodilators on rates of change of nasopharyngeal temperature and systemic vascular resistance during cardiopulmonary bypass in anaesthetized dogs. Aust N Z J Surg 1988; 58:327–333.

    Article  PubMed  CAS  Google Scholar 

  9. De Oliveira NC, Ashburn DA, Khalid F, Burkhart HM, Adatia IT, Holtby HM, Williams WG, Van Arsdell GS. Prevention of early sudden circulatory collapse after the Norwood operation. Circulation 2004; 110(Suppl 1):II133–138.

    PubMed  Google Scholar 

  10. De Oliveira NC, Van Arsdell GS. Practical use of alpha blockade strategy in the management of hypoplastic left heart syndrome following stage one palliation with a Blalock-Taussig shunt. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004: 7:11–15.

    Article  PubMed  Google Scholar 

  11. O’Blenes SB, Roy N, Konstantinov I, Bohn D, Van Arsdell GS. Vasopressin reversal of phenoxybenzamine-induced hypotension after the Norwood procedure. J Thorac Cardiovasc Surg 2002; 123:1012–1013.

    Article  PubMed  Google Scholar 

  12. Kiran U, Makhija N, Das SN, Bhan A, Airan B. Combination of phenoxybenzamine and nitroglycerin: effective control of pulmonary artery pressures in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2005; 19:274–275.

    Article  PubMed  Google Scholar 

  13. Weiner N: Drugs that inhibit adrenergic nerves and block adrenergic receptors. In: Goodman & Gillman, The Pharmacological Basis of Therapeutics, 6th Edition, New York, MacMillan Publishing Co, 1980. pp. 179–182.

    Google Scholar 

  14. O’Blenes SB, Roy N, Konstantinov I, Bohn D, Van Arsdell GS. Vasopressin reversal of phenoxybenzamine-induced hypotension after the Norwood procedure. J Thorac Cardiovasc Surg 2002; 123:1012–1013.

    Article  PubMed  Google Scholar 

References

  1. Tuncel M, Ram VC. Hypertensive emergencies. Etiology and management. Am J Cardiovasc Drugs 2003; 3:21–31.

    Article  PubMed  CAS  Google Scholar 

  2. Murphy DJ, Walker ME, Culp DA, Francomacaro DV. Effects of adrenergic antagonists on cocaine-induced changes in respiratory function. Pulm Pharmacol 1991; 4:127–134.

    Article  PubMed  CAS  Google Scholar 

  3. Koner O, Tekin S, Koner A, Soybir N, Seren S, Karaoglu K. Effects of phentolamine on tissue perfusion in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 1999; 13:191–197.

    Article  PubMed  CAS  Google Scholar 

  4. Molony D. Adrenaline-induced digital ischaemia reversed with phentolamine. ANZ J Surg. 2006; 76:1125–1126.

    Article  PubMed  Google Scholar 

  5. Galal MO, El-Naggar WI, Sharfi MH. Phentolamine as a treatment for poor mixing in transposition of the great arteries with adequate intra atrial communication. Pediatr Cardiol 2005; 26:444–445.

    Article  PubMed  CAS  Google Scholar 

  6. McPherson GA. Current trends in the study of potassium channel openers. Gen Pharmacol 1993; 24:275–281.

    Article  PubMed  CAS  Google Scholar 

References

  1. Post JB 4th, Frishman WH. Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies. J Clin Pharmacol 1998; 38(1):2–13.

    Google Scholar 

  2. White WB, Radfod MJ, Gonzales FM, et al. Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam. J Am Coll Cardiology 1988; 11:1118–1121.

    CAS  Google Scholar 

  3. Bednzarczyk EM, White WB, Munger MA, et al. Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension. Am J Cardiology 1989; 63:993–996.

    Article  Google Scholar 

References

  1. Zahka KG, Roland MA, Cutilletta AF, et al. Management of aortic arch interruption with prostaglandin E1 infusion and microporous expanded polytetrafluoroethylene grafts. Am J Cardiol 1980; 46:1001–1005.

    Article  PubMed  CAS  Google Scholar 

  2. Peled N, Dagan O, Babyn P, et al. Gastric-outlet obstruction induced by prostaglandin therapy in neonates. N Engl J Med 1992; 327:505–510.

    Article  PubMed  CAS  Google Scholar 

  3. Woo K, Emery J, & Peabody J. Cortical hyperostosis: a complication of prolonged prostaglandin infusion in infants awaiting cardiac transplantation. Pediatrics 1994; 93: 417–420.

    PubMed  CAS  Google Scholar 

  4. Kalloghlian AK, Frayha HH, deMoor MM. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion. Eur J Pediatr 1996; 155(3):173–174.

    Article  PubMed  CAS  Google Scholar 

References

  1. Bennett WM, Aronoff GR, Golper TA, et al. Drug Prescribing in Renal Failure. American College of Physicians, Philadelphia, PA, 1994.

    Google Scholar 

  2. Russell GI, Bing RF, Jones JA, et al. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype. Q J Med 1987; 65:845–852.

    PubMed  CAS  Google Scholar 

  3. Cinquegrani MP, Liang CS. Indomethacin attenuates the hypotensive action of hydralazine. Clin Pharmacol Ther 1986; 39:564–570.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA

    Associate Professor Stephen J. Roth MD, MPH

  2. Critical Care Medicine, Pediatrics and Surgery, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA

    Associate Professor Ricardo Munoz MD, FAAP, FCCM & Carol G. Schmitt PharmD

  3. Department of Pediatrics, Children's University Hospital of Geneva, Geneva, Switzerland

    Eduardo da Cruz MD

  4. The Heart Institute, Children's Hospital of Denver, Denver, CO, USA

    Jonathan Kaufman MD

  5. Pediatric Cardiology Unit, University Hospital of Geneva, Geneva, Switzerland

    Cécile Tissot MD

Authors
  1. Associate Professor Stephen J. Roth MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Associate Professor Ricardo Munoz MD, FAAP, FCCM
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carol G. Schmitt PharmD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eduardo da Cruz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jonathan Kaufman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cécile Tissot MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA

    Ricardo Munoz MD, FAAP, FCCM  & Carol G. Schmitt PharmD  & 

  2. Stanford University School of Medicine, Palo Alto, CA, USA

    Stephen J. Roth MD, MPH

  3. Children's University Hospital of Geneva, Geneva, Switzerland

    Eduardo da Cruz MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Roth, S.J., Munoz, R., Schmitt, C.G., da Cruz, E., Kaufman, J., Tissot, C. (2008). Vasodilators. In: Munoz, R., Schmitt, C.G., Roth, S.J., da Cruz, E. (eds) Handbook of Pediatric Cardiovascular Drugs. Springer, London. https://doi.org/10.1007/978-1-84628-953-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-953-8_4

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-952-1

  • Online ISBN: 978-1-84628-953-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation